$79.7 Million is the total value of Invenire Partners, LP's 29 reported holdings in Q1 2022. The portfolio turnover from Q4 2021 to Q1 2022 was 28.6% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
TTEC | Sell | TTEC Holdings Inc | $4,689,364,000 | -10.1% | 56,827 | -1.3% | 5.88% | +6.6% |
NOA | Sell | North American Construction Group Ltd | $4,018,218,000 | -26.5% | 278,270 | -22.7% | 5.04% | -12.8% |
UTI | Sell | Universal Technical Institute Inc | $2,657,106,000 | -7.2% | 300,238 | -18.0% | 3.33% | +10.0% |
ASPN | Sell | Aspen Aerogels Inc | $1,984,117,000 | -41.0% | 57,544 | -14.8% | 2.49% | -30.1% |
ASUR | Sell | Asure Software Inc | $1,544,167,000 | -28.3% | 259,524 | -5.6% | 1.94% | -15.0% |
SMLR | Exit | Semler Scientific Inc | $0 | – | -48,625 | -100.0% | -4.72% | – |
IJR | Exit | iShares Core S&P Small-Cap ETF | $0 | – | -85,236 | -100.0% | -10.33% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-05-13
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
DHI Group Inc | 4 | Q3 2022 | 7.9% |
Tetra Technologies Inc | 4 | Q3 2022 | 6.5% |
Harrow Health Inc | 4 | Q3 2022 | 8.4% |
TTEC Holdings Inc | 4 | Q3 2022 | 5.9% |
Clarus Corp | 4 | Q3 2022 | 5.9% |
Apyx Medical Corp | 4 | Q3 2022 | 6.5% |
InfuSystem Holdings Inc | 4 | Q3 2022 | 5.1% |
PAR Technology Corp | 4 | Q3 2022 | 4.9% |
Cantaloupe Inc | 4 | Q3 2022 | 5.2% |
Marcus Corp | 4 | Q3 2022 | 4.4% |
View Invenire Partners, LP's complete holdings history.
Latest filings
Type | Filed |
---|---|
SC 13G/A | 2023-03-31 |
SC 13G | 2023-01-23 |
13F-HR | 2022-11-14 |
13F-HR | 2022-08-15 |
13F-HR | 2022-05-13 |
13F-HR | 2022-02-14 |
D/A | 2019-03-12 |
D | 2018-01-02 |
View Invenire Partners, LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.